| Zanamivir |
| 5-(acetylamino)-4-[(aminoiminomethyl)amino]-2,6-anhydro-3,4,5-trideoxy-D-glycero-D-galacto-non-2-enonic acid |
| (CAS 139110-80-8) |
 |
| Description： |
Zanamivir is a sialic acid analog that inhibits neuraminidase release of newly replicated influenza virus particles.It has been shown to selectively inhibit the growth of influenza A and B viruses in plaque reduction assays with IC50 values ranging from 5 to 14 nM and to directly inhibit influenza A and B virus neuraminidases with IC50 values ranging from 0.6 to 7.9 nM in vitro. Intranasal zanamivir administration at 0.4 mg/kg twice daily can reduce mortality and viral titers in lung homogenates of mice infected with influenza. The efficacy and tolerabilbity of zanamivir has also been established in clinical trial.
|
| Product No. |
KT20097 |
| Product Name |
Zanamivir |
| Synonyms |
Relenza; GG 167; GR 121167X |
| Formal Name |
5-(acetylamino)-4-[(aminoiminomethyl)amino]-2,6-anhydro-3,4,5-trideoxy-D-glycero-D-galacto-non-2-enonic acid |
| CAS Number |
139110-80-8 |
| Molecular Formula |
C12H20N4O7 |
| Formula Weight |
332.3 |
| Formulation |
A crystalline solid |
| Purity |
98%min |
| Stability |
2 years |
| Storage |
-20°C |
| Shipping |
USD45 for Europe and USA. No shipping charge once amount reach USD500 |
| Quality Control |
HNMR,CNMR,LCMS,HPLC,IR,etc. |
| Price & Availability |
In Stock. Price Negotiated. |
|
| Related Products： |
Abacavir
Amprenavir
Atazanavir
Darunavir
Dolutegravir
Efavirenz
Elvitegravir
Emtricitabine
Etravirine
Indinavir
Lamivudine
Nelfinavir
|
|
